Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Vous n'êtes pas connecté
Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis. Current treatments could be more effective. Researchers from the University of Geneva and Geneva University Hospitals have discovered a specific marker on glioblastoma cells and created immune cells called CAR-T cells that can target and destroy these [...] Read Full Article At: Programming cells help to fight a brain tumor
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier...
Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could help the body fight back.
major breakthrough from scientists at the University of Virginia is changing how researchers think about Alzheimer’s disease. Instead of focusing...
major breakthrough from scientists at the University of Virginia is changing how researchers think about Alzheimer’s disease. Instead of focusing...
For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues. Researchers from the Wellcome...